MEDICLIN Aktiengesellschaft (FRA:MED)
Germany flag Germany · Delayed Price · Currency is EUR
3.020
-0.120 (-3.82%)
Last updated: Aug 1, 2025

Longboard Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
143115130171186184
Upgrade
Market Cap Growth
23.97%-11.68%-23.89%-8.16%1.03%-24.66%
Upgrade
Enterprise Value
498462507477526585
Upgrade
Last Close Price
3.082.232.493.083.713.87
Upgrade
PE Ratio
4.204.63-18.11127.41-
Upgrade
PS Ratio
0.180.150.170.240.270.28
Upgrade
PB Ratio
0.610.520.660.821.021.04
Upgrade
P/TBV Ratio
0.680.580.751.101.461.54
Upgrade
P/FCF Ratio
2.842.702.9916.652.791.91
Upgrade
P/OCF Ratio
1.531.431.674.942.271.55
Upgrade
EV/Sales Ratio
0.640.610.670.660.770.88
Upgrade
EV/EBITDA Ratio
4.436.457.6112.9117.9928.36
Upgrade
EV/EBIT Ratio
8.219.2012.1546.12186.12-
Upgrade
EV/FCF Ratio
9.9310.8711.6346.447.886.07
Upgrade
Debt / Equity Ratio
1.962.082.452.402.402.75
Upgrade
Debt / EBITDA Ratio
4.054.625.116.155.757.16
Upgrade
Debt / FCF Ratio
9.0810.9211.0148.956.595.05
Upgrade
Asset Turnover
0.870.850.850.800.770.74
Upgrade
Inventory Turnover
80.5779.7774.1667.6262.9063.31
Upgrade
Quick Ratio
1.681.731.841.391.141.11
Upgrade
Current Ratio
1.821.792.051.531.251.19
Upgrade
Return on Equity (ROE)
15.89%11.90%-5.29%4.95%0.83%-4.92%
Upgrade
Return on Assets (ROA)
4.23%3.52%2.90%0.72%0.20%-0.65%
Upgrade
Return on Capital (ROIC)
5.56%4.61%3.76%0.97%0.27%-0.85%
Upgrade
Return on Capital Employed (ROCE)
8.20%6.80%5.70%1.40%0.40%-
Upgrade
Earnings Yield
23.83%21.61%-8.28%5.52%0.78%-4.88%
Upgrade
FCF Yield
35.21%36.99%33.49%6.00%35.84%52.33%
Upgrade
Dividend Yield
1.32%1.80%----
Upgrade
Payout Ratio
5.60%-----
Upgrade
Total Shareholder Return
23.30%1.80%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.